Jefferies Reiterates Bullish View on AVEO Pharmaceuticals (AVEO) Following TIVO-1 Data
Tweet Send to a FriendGet Alerts AVEO Hot Sheet
Price: $2.81 -3.1%
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 13
Rating Summary:
1 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 13
Trade AVEO Now!
Jefferies reiterated their Buy rating and $30 price target on AVEO Pharmaceuticals (NASDAQ: AVEO) following detailed data from its TIVO-1 Phase 3 study demonstrating superiority of tivozanib over Nexavar.
The firm comments, "Two notable updates included bigger efficacy benefits as reported by investigators and also in subgroup analyses of patients who experienced hypertension. We continue to see the current valuation as a steep discount to the value of tivo as a competitive front-line treatment option in renal cell carcinoma."
For an analyst ratings summary and ratings history on AVEO Pharmaceuticals click here. For more ratings news on AVEO Pharmaceuticals click here.
Shares of AVEO Pharmaceuticals closed at $12.46 yesterday, with a 52 week range of $10.40-$21.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "Two notable updates included bigger efficacy benefits as reported by investigators and also in subgroup analyses of patients who experienced hypertension. We continue to see the current valuation as a steep discount to the value of tivo as a competitive front-line treatment option in renal cell carcinoma."
For an analyst ratings summary and ratings history on AVEO Pharmaceuticals click here. For more ratings news on AVEO Pharmaceuticals click here.
Shares of AVEO Pharmaceuticals closed at $12.46 yesterday, with a 52 week range of $10.40-$21.55.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- Albert Fried Downgrades Pandora (P) to Market Perform
- Compuware (CPWR) Estimates Trimmed, PT Raised at Jefferies
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
